JPH1157010A - Sleep differentiation - Google Patents
Sleep differentiationInfo
- Publication number
- JPH1157010A JPH1157010A JP9237794A JP23779497A JPH1157010A JP H1157010 A JPH1157010 A JP H1157010A JP 9237794 A JP9237794 A JP 9237794A JP 23779497 A JP23779497 A JP 23779497A JP H1157010 A JPH1157010 A JP H1157010A
- Authority
- JP
- Japan
- Prior art keywords
- sleep
- bedding
- neurotransmitters
- concentration
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術範囲】本発明は、寝具などの評価に
好適な睡眠の鑑別方法に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for identifying sleep which is suitable for evaluating bedding and the like.
【0002】[0002]
【従来の技術】睡眠は、人間を始めとする動物或いは植
物にとっても欠くことのできない、重要な生理的な行動
であり、睡眠にも例えばレム睡眠やノンレム睡眠等のよ
うに色々種類が存在することが知られており、良質な睡
眠と質のあまり良くない睡眠があることも知られてい
る。しかしながら良質の睡眠にはどの様な特性があり、
質のさほど良くない睡眠にはどの様な特性があるかはは
っきりとは解きあかされていない。更に、睡眠の特質を
知る手段としては現在行われているのは、脳波を測定し
たり、体の各所に於ける微電流を測定したりすることで
あり、これらはともに大がかりな装置を必要とするため
簡便に睡眠を評価することできない。2. Description of the Related Art Sleep is an important physiological action that is indispensable to animals and plants, including humans, and there are various types of sleep such as REM sleep and non-REM sleep. It is also known that there is good sleep and sleep of poor quality. However, what are the characteristics of good sleep?
The nature of poor sleep quality has not been fully elucidated. Further, as a means of knowing the characteristics of sleep, current methods of measuring brain waves and measuring small electric currents in various parts of the body are both required, which both require large-scale devices. Therefore, sleep cannot be evaluated easily.
【0003】上記の如く、生体に於いて睡眠の有する意
味は大きい為、これに大きな影響を与える寝具について
は、昨今、様々な製品が開発されている。しかしながら
上記の如く睡眠の評価そのものが困難を伴うため、的確
な評価が為されていないのが現状であると言わざるを得
ない。即ち、寝具を客観的、且つ、的確に評価する技術
の開発が望まれていた。[0003] As described above, sleep has a significant meaning in a living body, and various products have recently been developed for bedding that greatly influences this. However, as described above, it is difficult to evaluate the sleep itself, so it cannot be said that accurate evaluation has not been made at present. That is, the development of a technology for objectively and accurately evaluating bedding has been desired.
【0004】一方、ドーパミン、エピネフリン、ノルエ
ピネフリン、アセチルコリン等の神経伝達性物質と睡眠
の関係について全く何も知られていないのが現状であっ
た。On the other hand, at present, nothing is known about the relationship between neurotransmitters such as dopamine, epinephrine, norepinephrine and acetylcholine and sleep.
【0005】[0005]
【発明が解決しようとする課題】本発明はこの様な状況
下行われたものであり、寝具などの評価に好適な簡便で
的確な睡眠の鑑別方法を提供することを課題とする。SUMMARY OF THE INVENTION The present invention has been made in such a situation, and it is an object of the present invention to provide a simple and accurate sleep discriminating method suitable for evaluating bedding and the like.
【0006】[0006]
【課題の解決手段】本発明者らは、この様な状況に鑑み
て、寝具などの評価に好適な簡便で的確な睡眠の鑑別方
法を求めて鋭意研究を重ねた結果、血液などの体液中に
於けるエピネフリン等の神経伝達物質の濃度を測定する
ことにより、睡眠を的確に鑑別し得ることを見いだし発
明を完成させるに至った。以下、本発明について実施の
形態を中心に詳細に説明を加える。In view of such a situation, the present inventors have conducted intensive studies to find a simple and accurate sleep discrimination method suitable for evaluation of bedding and the like. The present inventors have found that sleep can be accurately distinguished by measuring the concentration of a neurotransmitter such as epinephrine in the present invention, and have completed the invention. Hereinafter, the present invention will be described in detail focusing on embodiments.
【0007】[0007]
(1)本発明の睡眠の鑑別法 本発明の睡眠の鑑別法は、神経伝達物質の体液に於ける
量の変化を指標とすることを特徴とする。ここで神経伝
達物質とは、生物に於いて、ニューロン間の情報伝達を
行う物質であって、例えば、ドーパミン、エピネフリ
ン、ノルエピネフリン等のカテコールアミン類やアセチ
ルコリン等のコリン類が例示でき、本発明ではこれらの
何れもが使用可能であるし、これらの単独の濃度、これ
らから選ばれる2種以上の濃度変化を指標にすることも
可能である。指標として好ましいものは交感神経系の神
経伝達物質であり、その中でもカテコールアミン類が好
ましく、特に好ましいのはエピネフリンである。又、こ
れらの神経伝達物質の量変化を測定する検体としては、
体液であれば特段の限定が無く、血液、唾液、尿、髄液
何れも可能であり、中でも血液が特に好ましい。又、量
の測定としては血液の場合は総血液量が一定とみなせる
ので濃度を測定することで代表できる。尿などの場合に
は、代謝量に対する濃度で代表できる。代謝量に対する
濃度としては、尿中濃度を尿中クレアチン濃度で除した
ものを使用することができる。又、測定のタイミングと
しては睡眠終了(起床)直後からその30分後後程度ま
でに行うのが好ましい。体液として血液を用いる場合、
この時の血中のエピネフリン等のカテコールアミン類の
量が少なく、アセチルコリン等のコリン類の量が多い場
合には睡眠が不足の状態にあり、好ましい睡眠が得られ
ていなかったと鑑別でき、カテコールアミンの量が多
く、コリン類の量が少ない場合には睡眠が充分であり、
好ましい睡眠が得られたと鑑別できる。これら神経伝達
物質の定量法は既に確立されており、例えば、蛍光化剤
を用いた高速液体クロマトグラフィー等により測定する
ことができる。更に、この様な測定を受託する業者もあ
るのでそれを利用することも可能である。かくの如く、
睡眠を鑑別することにより、その睡眠を得るのに用いた
寝具を評価することができるし、蓄積疲労や顕在化して
いない睡眠不足などを知ることができる。(1) Sleep Differentiation Method of the Present Invention The sleep differentiation method of the present invention is characterized by using a change in the amount of a neurotransmitter in a body fluid as an index. Here, a neurotransmitter is a substance that transmits information between neurons in an organism, and examples thereof include catecholamines such as dopamine, epinephrine and norepinephrine and cholines such as acetylcholine. Any of these can be used, and a single concentration thereof, or a change in two or more concentrations selected from these concentrations can be used as an index. Preferred as indicators are neurotransmitters of the sympathetic nervous system, among which catecholamines are preferred, and epinephrine is particularly preferred. Also, as a sample for measuring the change in the amount of these neurotransmitters,
There is no particular limitation as long as it is a bodily fluid, and any of blood, saliva, urine, and cerebrospinal fluid can be used, and blood is particularly preferable. In the case of blood, the measurement of the amount can be represented by measuring the concentration, since the total blood volume can be regarded as constant. In the case of urine or the like, it can be represented by the concentration with respect to the metabolic rate. As the concentration with respect to the metabolic amount, a value obtained by dividing the urine concentration by the urine creatine concentration can be used. It is preferable that the measurement be performed immediately after the end of sleep (wake-up) to about 30 minutes later. When using blood as body fluid,
At this time, when the amount of catecholamines such as epinephrine in the blood is small and the amount of choline such as acetylcholine is large, sleep is in a state of lack, and it can be discriminated that preferable sleep was not obtained, and the amount of catecholamine was determined. If the amount of choline is small, sleep is sufficient,
It can be determined that a good sleep has been obtained. Methods for quantifying these neurotransmitters have already been established and can be measured, for example, by high performance liquid chromatography using a fluorescent agent. In addition, some vendors accept such measurement, and it is also possible to use it. Like this,
By discriminating sleep, the bedding used to obtain the sleep can be evaluated, and accumulated fatigue and lack of sleep that have not become apparent can be known.
【0008】(2)本発明の寝具の評価法 本発明の寝具の評価法は、その寝具を用いて睡眠した場
合に得られる睡眠の良し悪しを指標にして評価すること
を特徴とする。即ち、例えば、寝る前に予め採血し、評
価すべき寝具で睡眠をとった後、再び採血し、これらの
血液に於ける神経伝達物質の量の変化を調べ、起きた直
後の交感神経系神経伝達物質の量が低下していなけれ
ば、その寝具は優れた寝具として評価できる。この低下
は連続的な数値として表現できるので、睡眠を定量的に
評価しうる。この評価法が適用しうる寝具の種類は特段
の限定はされず、例えば、掛け布団、敷き布団、マット
レス、敷布、布団カバー、枕、パジャマ、ネグリジェ等
が例示できる。これらの従来に於ける評価方法は、実使
用テストでの主観による評価の統計的解析によるしかな
く、客観的とは言い難い面もあったが、本発明によれば
客観的な数字として表せるので客観的評価が可能となっ
た。本発明の評価法では、起床後の体液に於けるカテコ
ールアミン類の量が多ければ、或いは、コリン類の量が
少なければ、その寝具は良い寝具であると評価できる。
又、その逆であればその寝具は良くないと評価できる。
特にカテコールアミン類の低下が就寝前に比べ50%以
下の低下である場合には優れた寝具と判断できる。(2) Method of Evaluating Bedding of the Present Invention The method of evaluating bedding of the present invention is characterized in that the quality of sleep obtained when sleeping using the bedding is evaluated as an index. That is, for example, blood is collected before going to bed, sleep is taken with the bedding to be evaluated, blood is collected again, changes in the amount of neurotransmitters in these bloods are examined, and the sympathetic nervous system If the amount of transmitter is not reduced, the bedding can be evaluated as an excellent bedding. Since this decrease can be expressed as a continuous numerical value, sleep can be evaluated quantitatively. The type of bedding to which this evaluation method can be applied is not particularly limited, and examples thereof include a comforter, a mattress, a mattress, a mattress, a futon cover, a pillow, pajamas, and a negligee. These conventional evaluation methods are based only on statistical analysis of subjective evaluation in actual use tests, and there are aspects that are hardly objective, but according to the present invention, they can be expressed as objective numbers. Objective evaluation became possible. In the evaluation method of the present invention, if the amount of catecholamines in the body fluid after waking up is large or the amount of choline is small, the bedding can be evaluated as a good bedding.
On the contrary, it can be evaluated that the bedding is not good.
In particular, when the decrease in catecholamines is 50% or less compared to before bedtime, it can be determined that the bedding is excellent.
【0009】[0009]
【実施例】以下に実施例を挙げて本発明について更に詳
細な説明を加えるが、本発明がこれら実施例にのみ限定
を受けないことは言うまでもない。The present invention will be described in more detail with reference to the following examples, but it goes without saying that the present invention is not limited only to these examples.
【0010】<実施例1>睡眠が健常なパネラー12名
と睡眠不足に悩むパネラー13名について、睡眠の前後
に採血し、カテコールアミン類であるエピネフリンの血
中濃度を測定し、睡眠後の血中エピネフリンの量変化を
調べた。エピネフリンの測定は外部の受託試験業者に依
頼して行った。結果を表1に示す。これより睡眠不足を
訴える群は有意にエピネフリンの低下が著しいことがわ
かる。これより、カテコールアミン類の低下の程度によ
り睡眠の良し悪しが鑑別できることがわかる。更に、エ
ピネフリンの低下率が50%を越えると睡眠の状況が悪
化することがわかる。<Example 1> Blood was collected from 12 healthy panelists and 13 panelists suffering from lack of sleep before and after sleep, and blood levels of epinephrine, a catecholamine, were measured. Changes in the amount of epinephrine were examined. Epinephrine was measured by an external contract tester. Table 1 shows the results. This indicates that the group that complains of lack of sleep significantly decreases epinephrine significantly. From this, it can be seen that sleep quality can be distinguished by the degree of decrease in catecholamines. Further, it can be seen that when the decrease rate of epinephrine exceeds 50%, the sleep situation deteriorates.
【0011】[0011]
【表1】 [Table 1]
【0012】<実施例2>パネラー3名を用いて睡眠試
験を行った。即ち、電極をパネラーに取り付け睡眠して
もらい、睡眠状況を脳波を指標に観察した。脳波のパタ
ーンより睡眠を良、普通、不良に鑑別した。又、実施例
1同様に睡眠の前後に於けるエピネフリンの量変化を測
定した。結果を表2に示す。これより、実施例1と同様
の結果が出ていることが判る。即ち、本発明の鑑別法に
より、脳波測定装置などのような、大がかりで高価な機
器を用いずとも、同様の精度で睡眠が鑑別しうることが
判る。Example 2 A sleep test was conducted using three panelists. That is, the electrodes were attached to a panel and the subject was allowed to sleep, and the sleep state was observed using brain waves as an index. Sleep was identified as good, normal, or poor based on the EEG pattern. In the same manner as in Example 1, changes in epinephrine before and after sleep were measured. Table 2 shows the results. This indicates that the same results as in Example 1 were obtained. That is, it can be understood that the sleep can be distinguished with the same accuracy without using a large-scale and expensive device such as an electroencephalogram measuring device by the distinguishing method of the present invention.
【0013】[0013]
【表2】 [Table 2]
【0014】<実施例3>3種の枕について、パネラー
10名を用いて実施例2と同様に睡眠の状況について調
べた。又、このものの使い勝手についてアンケートによ
り評価してもらった。評価は、評点2:非常に寝やす
い、評点1:寝やすい、評点0.5:やや寝にくい、評
点0:寝にくいの基準に従って評価してもらった。結果
を表3に示す。これより、寝具の評価とエピネフリンの
低下率が大きく関わっていることが判る。又、この結果
より本発明の睡眠の鑑別法を用いて寝具の評価ができる
ことが判る。<Embodiment 3> Sleep conditions of three types of pillows were examined in the same manner as in Embodiment 2 using ten panelists. The usability of this product was evaluated by a questionnaire. The evaluation was based on the following criteria: score 2: very easy to sleep, score 1: easy to sleep, score 0.5: slightly difficult to sleep, score 0: difficult to sleep. Table 3 shows the results. This indicates that the evaluation of the bedding and the epinephrine reduction rate are significantly related. In addition, the results show that the bedding can be evaluated using the sleep identification method of the present invention.
【0015】[0015]
【表3】 [Table 3]
【0016】<実施例4>本発明の睡眠の鑑別法を適用
して、寝具の良否を評価した。即ち、30℃で2日、5
℃で2日、パネラー5名を用いて、通常の綿を詰めた布
団と羽根布団との寝具合の比較を行った。30℃、5℃
に於いて、パネラーには1日は綿布団に寝てもらい、も
う一日は羽根布団に寝てもらった。就寝の前後に血液を
採取しエピネフリンの平均低下率を測定した。結果をエ
ピネフリンの平均低下率として、表4に示す。これより
従来言われている、暑い状況では綿布団の方が心地よ
く、寒い状況では羽根布団の方が心地よいことが裏付け
られた。即ち、本発明によれば的確に寝具の評価ができ
ることが判る。Example 4 The bedding quality was evaluated by applying the sleep discrimination method of the present invention. That is, 5 days at 30 ° C for 2 days.
Two days at 5 ° C., five panelists compared the bedding condition of a futon filled with ordinary cotton and a duvet. 30 ° C, 5 ° C
At, the panelists had to sleep on a cotton futon for one day and another for a day. Blood was collected before and after going to bed and the average decrease in epinephrine was measured. The results are shown in Table 4 as the average reduction rate of epinephrine. It has been confirmed that the cotton futon is more comfortable in hot conditions and the duvet is more comfortable in cold conditions. That is, according to the present invention, it can be understood that the bedding can be accurately evaluated.
【0017】[0017]
【表4】 [Table 4]
【0018】[0018]
【発明の効果】本発明によれば、寝具などの評価に好適
な簡便で的確な睡眠の鑑別方法を提供することができ
る。According to the present invention, it is possible to provide a simple and accurate sleep discriminating method suitable for evaluating bedding and the like.
Claims (7)
る、睡眠の鑑別方法。1. A method for distinguishing sleep using the concentration of a neurotransmitter in a body fluid as an index.
求項1に記載の鑑別方法。2. The method according to claim 1, wherein the neurotransmitter is epinephrine.
載の睡眠の鑑別方法。3. The method according to claim 1, wherein the body fluid is blood.
神経伝達物質の濃度を測定し、当該神経伝達物質の濃度
を指標として、睡眠を鑑別することを特徴とする請求項
1〜3の何れか一項に記載の睡眠の鑑別方法。4. The method according to claim 1, wherein a body fluid is collected immediately after waking up, a concentration of the neurotransmitter in the body fluid is measured, and sleep is identified using the concentration of the neurotransmitter as an index. The method for identifying sleep according to any one of the above.
の鑑別方法により、鑑別された睡眠の質を指標とする寝
具の評価方法。5. A method of evaluating bedding using the sleep quality determined by the sleep determination method according to claim 1 as an index.
の鑑別方法に於いて、睡眠前に於ける濃度のに対する、
神経伝達物質の濃度の低下が50%以下であることを良
とする、請求項5に記載の寝具の評価方法。6. The method for distinguishing sleep according to any one of claims 1 to 4, wherein:
The bedding evaluation method according to claim 5, wherein the decrease in the concentration of the neurotransmitter is preferably 50% or less.
の鑑別方法に於いて、睡眠前に於ける濃度のに対する、
神経伝達物質の濃度の低下が50%以下であることを特
徴とする、寝具。7. The method for distinguishing sleep according to any one of claims 1 to 4, wherein:
A bedding characterized by a decrease in neurotransmitter concentration of 50% or less.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9237794A JPH1157010A (en) | 1997-08-19 | 1997-08-19 | Sleep differentiation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9237794A JPH1157010A (en) | 1997-08-19 | 1997-08-19 | Sleep differentiation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH1157010A true JPH1157010A (en) | 1999-03-02 |
Family
ID=17020532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9237794A Pending JPH1157010A (en) | 1997-08-19 | 1997-08-19 | Sleep differentiation |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH1157010A (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006149469A (en) * | 2004-11-25 | 2006-06-15 | Delta Tooling Co Ltd | Method and device for evaluating human body supporting structure |
| US10561509B2 (en) | 2013-03-13 | 2020-02-18 | DePuy Synthes Products, Inc. | Braided stent with expansion ring and method of delivery |
| US10603157B2 (en) | 2013-03-13 | 2020-03-31 | DePuy Synthes Products, Inc. | Braid implant delivery and retraction device with distal engagement |
| US10821010B2 (en) | 2014-08-27 | 2020-11-03 | DePuy Synthes Products, Inc. | Method of making a multi-strand implant with enhanced radiopacity |
| US10821008B2 (en) | 2016-08-25 | 2020-11-03 | DePuy Synthes Products, Inc. | Expansion ring for a braided stent |
| US10893963B2 (en) | 2018-08-06 | 2021-01-19 | DePuy Synthes Products, Inc. | Stent delivery with expansion assisting delivery wire |
| US11090175B2 (en) | 2018-07-30 | 2021-08-17 | DePuy Synthes Products, Inc. | Systems and methods of manufacturing and using an expansion ring |
| US11129738B2 (en) | 2016-09-30 | 2021-09-28 | DePuy Synthes Products, Inc. | Self-expanding device delivery apparatus with dual function bump |
| US11357648B2 (en) | 2018-08-06 | 2022-06-14 | DePuy Synthes Products, Inc. | Systems and methods of using a braided implant |
-
1997
- 1997-08-19 JP JP9237794A patent/JPH1157010A/en active Pending
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006149469A (en) * | 2004-11-25 | 2006-06-15 | Delta Tooling Co Ltd | Method and device for evaluating human body supporting structure |
| US11452623B2 (en) | 2013-03-13 | 2022-09-27 | DePuy Synthes Products, Inc. | Braided stent with expansion ring and method of delivery |
| US10561509B2 (en) | 2013-03-13 | 2020-02-18 | DePuy Synthes Products, Inc. | Braided stent with expansion ring and method of delivery |
| US10603157B2 (en) | 2013-03-13 | 2020-03-31 | DePuy Synthes Products, Inc. | Braid implant delivery and retraction device with distal engagement |
| US11529249B2 (en) | 2013-03-13 | 2022-12-20 | DePuy Synthes Products, Inc. | Braided stent with expansion ring and method of delivery |
| US10821010B2 (en) | 2014-08-27 | 2020-11-03 | DePuy Synthes Products, Inc. | Method of making a multi-strand implant with enhanced radiopacity |
| US10821008B2 (en) | 2016-08-25 | 2020-11-03 | DePuy Synthes Products, Inc. | Expansion ring for a braided stent |
| US11129738B2 (en) | 2016-09-30 | 2021-09-28 | DePuy Synthes Products, Inc. | Self-expanding device delivery apparatus with dual function bump |
| US12064363B2 (en) | 2016-09-30 | 2024-08-20 | DePuy Synthes Products, Inc. | Self-expanding device delivery apparatus with dual function bump |
| US11090175B2 (en) | 2018-07-30 | 2021-08-17 | DePuy Synthes Products, Inc. | Systems and methods of manufacturing and using an expansion ring |
| US11497638B2 (en) | 2018-07-30 | 2022-11-15 | DePuy Synthes Products, Inc. | Systems and methods of manufacturing and using an expansion ring |
| US11357648B2 (en) | 2018-08-06 | 2022-06-14 | DePuy Synthes Products, Inc. | Systems and methods of using a braided implant |
| US10893963B2 (en) | 2018-08-06 | 2021-01-19 | DePuy Synthes Products, Inc. | Stent delivery with expansion assisting delivery wire |
| US12004977B2 (en) | 2018-08-06 | 2024-06-11 | DePuy Synthes Products, Inc. | Systems and methods of using a braided implant |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Verschelden et al. | Compliance with and accuracy of daily self-assessment of peak expiratory flows (PEF) in asthmatic subjects over a three month period | |
| Couret et al. | Reliability of standard pupillometry practice in neurocritical care: an observational, double-blinded study | |
| Growdon | Biomarkers of Alzheimer disease | |
| Levitt et al. | Validating the TMJ scale in a national sample of 10,000 patients: demographic and epidemiologic characteristics. | |
| Delgado-Corcoran et al. | Exhaled nitric oxide reflects asthma severity and asthma control | |
| Tranel | Neuropsychological assessment | |
| Poceta et al. | Circadian rhythm of CSF monoamines and hypocretin-1 in restless legs syndrome and Parkinson’s disease | |
| Yamada et al. | Preliminary results of moisture checker for Mucus in diagnosing dry mouth | |
| Parker et al. | The accuracy of self-reported smoking status assessed by cotinine test strips | |
| Rebuck et al. | The accuracy of a handheld portable spirometer | |
| Jean–Louis et al. | Sleep estimation from wrist activity in patients with major depression | |
| Mikami et al. | Validity of clinical diagnostic criteria for sleep bruxism by comparison with a reference standard using masseteric electromyogram obtained with an ultraminiature electromyographic device | |
| US20220218314A1 (en) | Body temperature diagnostics | |
| JPH1157010A (en) | Sleep differentiation | |
| Moodley et al. | Exhaled nitric oxide is elevated in patients with progressive systemic sclerosis without interstitial lung disease | |
| Harris et al. | Patient outcomes: assessment issues for the CNS | |
| Hansen et al. | The accuracy of the frequency–volume chart: comparison of self‐reported and measured volumes | |
| Rani et al. | Factors associated with clinical and perceived oral malodor among dental students | |
| Trahan | Judgment of line orientation in patients with unilateral cerebrovascular lesions | |
| Tomita et al. | Comparison of sleep diary and actigraphy to evaluate total sleep time in hypersomnia patients | |
| Palta et al. | Pulmonary testing using peak flow meters of very low birth weight children born in the perisurfactant era and school controls at age 10 years | |
| Allen et al. | Measures of alcohol consumption in perspective | |
| Good et al. | Unirhinal norms for the University of Pennsylvania smell identification test | |
| Miller et al. | The interpretation of spirometric measurements in epidemiologic surveys | |
| Leischow et al. | An evaluation of niccheck i®: A dipstick method for analyzing nicotine and its metabolites |